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ABSTRACT
The Role of Stress in Recovery of Function after Spinal Cord Injury.  (August 2007)
Stephanie Nicole Washburn, B.S.; M.S., Texas A&M University
Chair of Advisory Committee: Dr. James W. Grau
Research has shown that exposure to just 6 minutes of uncontrollable shock 24
hours following contusion injury impairs locomotor recovery and leads to greater tissue
loss at the injury epicenter. Uncontrollable shock is known to elevate corticosterone
levels in intact rats and corticosterone exacerbates cell death in the hippocampus
following injury, suggesting the effects may be related to a stress-induced release of
corticosterone.  Uncontrollable shock also affects other indices of stress including,
spleen weight and norepinephrine, and has been shown to elevate pro-inflammatory
cytokines.  The present experiments were designed to assess whether uncontrollable
shock has similar effects after contusion injury.
Experiment 1 examined whether injury itself produced a stress response.
Subjects received anesthesia alone, a laminectomy, or a contusion injury.  Twenty-four
hours later, they were restrained for 6 minutes and blood was collected from the leg.
They were sacrificed 24 hours later and spleens were weighed, and plasma
corticosterone and norepinephrine were assessed using ELISAs.  IL-1! and IL-6 levels
at the injury site were also measured using an ELISA.  Contusion injury had no impact
on any of the biological outcomes.  For Experiment 2, subjects received 6 minutes of
uncontrollable tailshock or an equivalent amount of restraint.  Subjects were sacrificed 6,
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24, 72, or 168 hours later.  Uncontrollable shock caused a decrease in spleen weight and
increased plasma corticosterone within 24 hours.  Increases in IL-1! and IL-6 were also
seen.  Morphine was used in Experiment 3 to block the “psychological” component of
uncontrollable shock.  Subjects received morphine (20 mg/kg; i.p.) or saline 30 minutes
prior to uncontrollable shock and were sacrificed 24 hours later.  Morphine did not
prevent the consequences of uncontrollable shock and, in some cases, potentiated its
effects.  The effect of controllability was examined in Experiment 4.  After receiving a
contusion injury, subjects received either controllable (master) or uncontrollable (yoked)
legshock over the course of 2 days.  A third group served as unshocked controls.  Master
subjects did not differ from yoked subjects on any of the biological outcomes measured.
Unshocked subjects, however, exhibited an increase in corticosterone, IL-6, and blood
monocytes.
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1CHAPTER I
INTRODUCTION
Spinal cord injury is a devastating event characterized by paralysis below the site
of injury, loss of bladder and bowel function, and in many cases, the development of
neuropathic pain.  According to the Christopher and Dana Reeve foundation website,
there are approximately 250,000 people currently living with a spinal cord injury, with
about 11,000 cases reported each year.  The majority (> 50%) of these people are
between the ages of 15 and 29 years old.  The fact that spinal cord injury occurs early in
life makes it especially difficult for the individual financially, as well as, emotionally.  It
is estimated that the lifetime cost for an individual injured at the age of 25 is $2.8 million
and overall, cost the United States an estimated $9.7 billion each year (Berkowitz, 1998).
However, these figures only account for the direct medical costs associated with the
injury and does not include costs for mental health care.  Approximately 30% of patients
will have at least one major depressive episode as a result of the loss of function and
chronic pain associated with spinal cord injury (Elliot & Frank, 1996).  On average,
these individuals exhibit less function than non-depressed patients.  The reason for this
may be motivational, however recent research from our laboratory suggests that both the
psychological and physiological aspects of injury may contribute to loss of function.
This dissertation follows the style and format of Behavioral Neuroscience.
2Using an animal model, we have shown that a commonly used stressor,
uncontrollable stimulation, undermines recovery of function after spinal cord injury
(Grau et al., 2004).  This loss of function appears to result from tissue loss at the injury
site, however the mechanism through which this occurs remains unknown.  My
dissertation was designed to further assess the impact of stress on recovery of function
after injury.  Specifically, it examines whether uncontrollable shock engages
physiological systems related to the stress response and thereby potentiates secondary
damage after spinal cord injury.
To understand how uncontrollable shock may potentiate secondary damage it is
essential to understand the injury process.  In the subsequent sections, I will outline the
injury process, beginning with the acute phase and continuing into the chronic stages.
Next, I will discuss how stress can affect these processes.
Injury Process
Spinal cord injury follows a stereotypical progression of biological changes that
consist of vascular, biochemical, inflammatory, cellular and molecular events.  These
changes begin at the moment of impact and persist for months.  To better understand the
injury process, researchers have broken it down into 3 stages consisting of the acute
stage, secondary or subacute stage, and chronic stage.  The acute stage defines the first
24 hours following the injury.  It is a critical stage because what happens during this
timeframe can dramatically alter the processes involved in the secondary and chronic
stages.  The first notable event during the acute stage is the development of gray matter
hemorrhage.  This area of hemorrhage continues to spread both rostrally and caudally
3and ultimately extends into the white matter within hours after injury (Dumont et al.,
2001; Norenberg, 2004; Osterholm, 1974).  This expanding area of hemorrhage is
accompanied by edema and subsequent ischemia.  Vasogenic edema causes a break
down of the blood-spinal cord barrier and is believed to result in diminished blood flow
to the injury site (Griffiths & Miller, 1974).  Ischemia, which often results from edema,
is thought to initiate a cascade of secondary events that culminate in excitoxicity (Amar
& Levy, 1999; Carlson & Gorden, 2002; Choi & Rothman, 1990; Rothman & Olney,
1986; Tymianski & Tator, 1996).  The term excitotoxicity was developed to describe the
neuronal injury and cell loss that result from excessive glutamate receptor activation
(Dumont et al., 2001).  The first step in excitoxicity is ATP-depletion and the subsequent
dysfunction of energy-dependent processes that maintain cellular homeostasis.  This loss
of homeostasis leads to an ionic dysregulation that causes swelling of the cell and
changes in membrane polarization that promote the release of excitatory amino acids,
such as glutamate, from synaptic vesicles (Amar and Levy, 1999; Hulsebosch, 2002).
Furthermore, inactivation of cellular uptake mechanisms in both neurons and glia due to
hypoxic ATP-depletion contributes to the accumulation of extracellular glutamate (Amar
& Levy, 1999).  This accumulation of excitatory amino acids in the extracellular space
can reach toxic levels within 15 minutes after injury (Hulsebosch, 2002). A number of
other neuroactive substances, which are also believed to contribute to secondary damage,
are also released acutely in the spinal cord in response to injury including,
norepinephrine (Osterholm & Matthews, 1972), histamine (Naftchi et al., 1974),
4dopamine (Faden et al., 1981), serotonin (Brodner & Dohrmann, 1977; Liu et al., 1990)
and dynorphin (Faden et al., 1985).
  Binding of glutamate to NMDA receptors allows the influx of calcium into the
cell, which initiates a number of calcium-dependent processes, such as the production of
free radicals and lipid peroxidation (Amar & Levy, 1999).  If levels of intracellular
calcium remain elevated it results in what has been deemed the “final common pathway
of toxic cell death in the CNS” (Dumont et al., 2001) and is considered “one of the most
significant pathophysiological events after spinal cord injury” (Yezierski, 2002).  This
destructive process is initiated within 8 hours after injury (Beattie et al., 2002) when
high intracellular calcium concentrations activate the intrinsic pathway of apoptosis.
Activation of this pathway causes mitochondrial damage and release of cytochrome c.
Cytochrome c couples with apoptosis activating factor-1 (Apaf-1) to activate the inducer
caspase, caspase-9, which subsequently engages the effector caspases, caspase-3 and –6
to induce cell death (Dumont et al., 2001; Okonkwo & Stone, 2003).
During apoptosis, cells exhibit condensation of chromatin in the nucleus, nuclear
shrinkage, and DNA fragmentation with intact membranes and organelle structure.  An
apoptotic cell eventually shrivels, pulls away from the surrounding cells, and is cleared
through phagocytosis.  Unlike necrosis, apoptosis does not produce an inflammatory
response (Chu et al., 2002; Lu, Ashwell, & Waite, 2000).  Apoptosis has been noted in
most CNS cell types, including neurons, oligodendrocytes, microglia, and astrocytes
(Dumont et al., 2001; Yong et al., 1998).  Apoptosis generally begins within 4 hours
after injury and persists at the injury site for 24 hours.  Given its delayed timecourse and
5the fact apoptotic cell death greatly influences the amount of function retained, apoptosis
has been a target for experimental treatments aimed at preserving function.
The damage to axons during the initial physical trauma of spinal cord injury is
one of the factors contributing to the loss of oligodendrocytes in the days following
injury.  The axons are stretched rather than torn which causes damage to the nodes of
Ranvier leading to a disruption of axoplasmic flow.  This disruption causes axonal
swelling and disconnection from the cell body over time (Faden, 1993).  The
degeneration of axons resulting from the initial insult occurs within the first few hours,
followed by the complete breakdown of the myelin sheaths by 1 day postinjury (Blight,
1992; Profyris et al., 2004).  This destructive process following the initial mechanical
injury results in significant loss of axons, particularly medium and large diameter axons
(Rosenberg, Zai, & Wrathall, 2005) and the loss of trophic support to the surrounding
oligodendrocytes (Profyris et al., 2004).  This contributes to apoptosis in
oligodendrocytes, which causes widespread Wallerian degeneration over the course of
months following spinal cord injury.
The secondary, or subacute phase, of spinal cord injury begins approximately 48
hours after injury and lasts for about 3 weeks (Days 2-21).  During this phase, edema
and hemorrhage are still present but begin to subside.  Areas of hemorrhage begin to
cavitate and the lesion begins to expand, doubling in size within 3 days postinjury, as
neurons and glial cells continue to be lost through apoptosis (Liu et al., 1997).  By day 7,
multiple cavitations are present and cysts begin to develop in the central necrotic region
(Carlson & Gorden, 2002; Liu et al., 1997).  Over time, the injury site evolves into a
6cystic cavity filled with activated microglia and phagocytic macrophages surrounded by
reactive astrocytes that form the glial scar (Profyris et al., 2004; Schwab & Bartholdi,
1996).  This scar separates the injured tissue from the normal tissue and serves as a
barrier to axonal regeneration.  At the same time, extensive demyelination occurs so that
by day 7, small patches of naked axons are common (Gledhill, Harrison, & McDonald,
1973; Gledhill & McDonald, 1977; Griffiths & McCulloch, 1983; Wakefield &
Eidelberg, 1975).
The last stage of spinal cord injury is the chronic phase.  In this phase, the injury
has stabilized and is undergoing very little additional changes.  The central lesion
undergoes only modest expansion during this time (Liu et al., 1997). The cavity, which
is filled with granular debris, fascicles of small myelinated and unmyelinated axons,
myelin fragments, and invading blood vessels (Hausmann, 2003), becomes well defined.
The glial scar thickens through the process of reactive gliosis as activated astrocytes
surround the cavity, imposing a chemical and physical barrier to regeneration (Bandtlow
& Schwab, 2000; Caroni & Schwab, 1988; Chen et al., 2000; Fawcett, 1997; GrandPre
et al., 2000; Niederost et al., 1999; Pasterkemp et al., 1999; Wang et al., 2002).  The
chronic lesion is an ellipsoidal cystic cavity surrounded by activated astrocytes and a
peripheral rim of spared axons undergoing demyelination (Beattie et al., 2002; Carlson
& Gordon, 2002; Hausmann, 2003).  Apoptosis of oligodendrocytes occurs for weeks
following injury, contributing to the number of fibers that undergo Wallerian
degeneration in the first 6 months (Crowe et al., 1997; Grossman, Rosenberg, &
Wrathall, 2001; Li et al., 1999; Schwab & Bartholdi, 1996; Shuman, Bresnahan, &
7Beattie, 1997).  At 1 month, some of the fibers are completely devoid of myelin but the
majority exhibits abnormally thin sheaths that surround normal looking axons (Harrison
& McDonald, 1977).  Over the course of 3-6 months there is a marked reduction in fiber
density indicative of complete degeneration of many fibers (Schwab & Bartholdi, 1996).
These fibers retract considerable distances (up to 5 mm) at this time (Hill, Beattie, &
Bresnahan, 2001; Oudega et al., 1999; Pallini, Fernandez, & Sbriccoli, 1988).
Immune Response
An immune response is generated immediately following spinal cord injury as
endothelial cells within the damaged tissue begin to produce pro-inflammatory cytokines
and chemoattractants, which ultimately cause neutrophils to migrate to the injury site
(Carlson et al., 1998). Whether this immune response is beneficial or detrimental to
recovery remains controversial.  For example, both neutrophils and macrophages
(peripheral and resident microglia) are thought to contribute to the secondary damage
that occurs following spinal cord injury (Bethea, 2000; Popovich et el., 2002; Taoka et
al., 1997).  However, they can also promote axonal regeneration (Rabchevsky & Streit,
1997; Rapalino et al., 1998).  Neutrophil infiltration occurs within 3 hours postinjury
(Taoko & Okajima, 2000) and peaks at 24 hours (Carlson et al., 1998).  Once there,
neutrophils produce cytokines that stimulate leukocyte chemotaxis and activate glia
(Profyris et al., 2004).  They also release histolytic enzymes, reactive oxygen species and
pro-inflammatory substances, which can lead to further inflammation and tissue damage
(Hamada et al., 1996; Taoka et al., 1997; Xu et al., 1990).
8Peripheral macrophages and activated microglia begin to infiltrate the injured
spinal cord within 24 hours and peak infiltration occurs between 3 and 7 days (Blight,
1992; Carlson et al., 1998; Popovich, Wei, & Stokes, 1997).  Lymphocytes begin to
appear within 3 days and peak infiltration generally occurs at 7 days postinjury
(Popovich et al., 1997). The emergence of immune cells at the injury site is, not
surprisingly, accompanied by an increase in the pro-inflammatory cytokines, tumor
necrosis factor-! (TNF-!), interleukin-1" (IL-1"), and interleukin-6 (IL-6).  In general,
these cytokines are upregulated in the spinal cord within 6 hours after a contusion injury
and return to normal levels within 48 hours (Nakamura et al., 2003; Nesic et al., 2001;
Pineau & LaCroix, 2007; Wang, Olschowka, & Wrathall, 1997; Wang et al., 2005; Yang
et al., 2005).
Role of Stress
Trauma to other parts of the body, especially the limbs, often accompany spinal
cord injury and provide a source of nociceptive input to the spinal cord.  This input acts
as a physiological stressor and, depending on injury severity, may also serve as a
psychological form of stress if it is perceived as painful.  Physiological and
psychological stressors initiate a cascade of events collectively known as the “stress
response” that begins with the activation of the hypothalamic-pituitary-adrenal (HPA)
axis and overall sympathetic arousal, and culminates in the release of glucocorticoids
into the bloodstream.  At low levels, such as that observed during mildly stressful events,
glucocorticoids facilitate learning and memory (McEwen & Sapolsky, 1995).  However,
higher concentrations, induced by severe or chronic stressors, have detrimental effects
9on these processes.  This presumably reflects a glucocorticoid-mediated loss of neurons
in areas of the brain important for learning and memory, such as the hippocampus
(McEwen & Sapolsky, 1995).  Interestingly, the impact of stress on the secondary
damage that occurs after spinal cord injury has received very little attention.
We have shown that uncontrollable shock, which is routinely used in animal
models of stress, impairs locomotor recovery, delays recovery of bladder function,
increases mortality and spasticity, and exacerbates tissue loss after spinal cord contusion
injury (Grau et al., 2004). Preliminary data suggest that these effects are related to a
stress-induced release of corticosterone.  For example, we have shown that
uncontrollable shock causes an elevation of corticosterone in rats with a spinal cord
injury that persists for up to 72 hours (Washburn et al., 2006).  This result complements
earlier findings that uncontrollable shock increases corticosterone in intact rats (Maier et
al., 1986).  Increases in corticosterone have been shown to potentiate cell loss in the
CNS (Armanini et al., 1990; Chou, 1998).  Although the mechanism underlying this
glucocorticoid-mediated cell loss remains unknown, it appears that pro-inflammatory
cytokines may play a role. For example, increases in pro-inflammatory cytokines are
often correlated with increases in corticosterone (Turnbull et al., 1994; Zhou et al., 1993)
and cell loss after injury (Nesic et al., 2001).  Many types of stressors, including
uncontrollable shock, have been shown to elevate pro-inflammatory cytokines (LeMay,
Vander, & Kluger, 1990; Nguyen et al., 1998; O’Connor et al., 2003). Exposure to
footshocks causes an increase in IL-1" in the brain as well as peripheral increases of IL-
" (Maier & Watkins, 1998; Nguyen et al., 2000; O’Connor et al., 2003).  The release of
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IL-" is believed to activate macrophages and enhance leukocyte migration to areas of
injury (Griffis, Compton, & Doering, 2006).  The increase in corticosterone observed in
spinal cord injured rats after exposure to uncontrollable shock may be accompanied by
an increase in pro-inflammatory cytokines, which in turn may contribute to cell loss and
impaired recovery of function.
Uncontrollable shock consists of two components that can induce a stress
response.  The first is the physiological component, which consists of the nociceptive
input itself.  The second is the psychological component, which consists of the
perception of pain caused by the nociceptive input.  The relative contribution of these
two components to the consequences of uncontrollable shock remains unknown.  In
contused subjects, who retain some sensory function, these components must be
separated.  Morphine is often used to prevent the perception of pain and therefore can be
used to block the psychological component.  We have previously shown that morphine
has no impact on the consequences of uncontrollable shock after contusion injury (Hook
et al., 2007).  This suggests that the nociceptive input itself plays a greater role than the
psychological experience of pain in the behavioral outcome of uncontrollable shock.
However, it is not known whether morphine treatment has any impact on the
biochemical consequences of shock.  If corticosterone is a key player, as suggested by
preliminary data, then morphine treatment during shock exposure should have no effect
on corticosterone levels or pro-inflammatory cytokine expression.  It is possible that
morphine may potentiate the biological consequences of uncontrollable shock given that
others have shown that morphine increases plasma levels of corticosterone
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(Budziszewska et al., 1999; Laorden & Milanes, 1999; Mellon & Bayer, 2001; Milanes,
Puig, & Vargas, 1993; Simon, George, & Garcia, 1975) and elevates circulating levels of
IL-1" and IL-6 (Bertolucci, Perego, & Simoni, 1996; Johnston et al., 2004; Houghtling
& Bayer, 2002; Houghtling et al., 2000).
Another factor that may influence both the behavioral and the biochemical
properties of shock exposure is the degree of controllability.  Uncontrollable shock leads
to a phenomenon known as “learned helplessness”, in which subjects exhibit a
behavioral, cognitive, and emotional deficit following exposure to inescapable,
uncontrollable shock (Seligman, 1975).  Subjects exposed to the same duration and
frequency of controllable shock do not develop “learned helplessness”, suggesting that it
is not the shock per se that causes the behavioral, cognitive, and emotion deficits but
rather the degree of perceived controllability.  A number of biochemical alterations have
been implicated in the development of “learned helplessness”, including dysregulation of
the noradrenergic system.  Uncontrollable shock leads to a transient increase in
norepinephrine followed by a decrease in norepinephrine in the locus coeruleus,
hypothalamus, and hippocampus that persists for 24 hours.
Previous work has shown that controllability eliminates the consequences of
shock after contusion injury.  Subjects given the opportunity to control shock exposure
did not show any locomotor impairment relative to unshocked controls (Grau et al.,
2004).  If corticosterone is involved in the behavioral consequences of uncontrollable
shock, then we would expect subjects given control to have corticosterone levels
comparable to unshocked subjects.  Interestingly, others have shown that controllability
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does not prevent the increase in corticosterone levels seen after shock exposure (Maier et
al., 1986).  This suggests that increases in corticosterone per se do not impact locomotor
recovery.  However, uncontrollable shock may cause a dysregulation of corticosterone.
Our finding that corticosterone stays elevated in subjects that received uncontrollable
shock for up to 72 hours supports this hypothesis (Washburn et al., 2006).
Specific Aims
The following set of experiments was designed to elucidate the mechanisms
underlying the behavioral consequences of uncontrollable shock.  It was divided into 4
experiments that focus on the major aspects of stress after injury.  Table 1 outlines these
experiments.  The first experiment characterized the impact of the contusion injury itself
on biological outcomes.  It focused on some of the major players implicated in the
consequences of stress:  corticosterone, norepinephrine, and pro-inflammatory cytokines.
We predict that the contusion injury will act as a stressor and produce a stress response
characterized by increases in corticosterone and norepinephrine. Others have shown that
the injury itself causes an increase in corticosterone (Popovich et al., 2001).  They also
showed that it causes an increase in pro-inflammatory cytokines at the injury site
(Nakamura et al., 2003; Nesic et al., 2001; Pineau & LaCroix, 2007; Wang et al., 1997;
Wang et al., 2005; Yang et al., 2005).  We expect similar findings.  We also expected
that contusion injury would lead to a decrease in spleen weight given that other stressors
are known to have this effect (Sumova & Jakoubek, 1989; Yamamotova et al., 2000).
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The second experiment assessed the impact of uncontrollable shock on these
same biological outcomes over time. We have previously reported that subjects exposed
to uncontrollable shock have diminished recovery of function and greater lesions at the
injury site compared to unshocked controls (Grau et al., 2004).  In that study, locomotor
recovery was assessed over the course of 6 weeks and histological analysis occurred
shortly thereafter.  Although our basic analysis of tissue sparing at the lesion site
provided an explanation for the diminished recovery, it did not address how
uncontrollable shock could cause cell loss. Experiment 2 of the current study was
designed to address this issue.  We predict that uncontrollable shock will induce a stress
response, resulting in increases in corticosterone and norepinephrine and a decrease in
spleen weight.  We also expect to find an increase in pro-inflammatory cytokines that
could contribute to cell death and loss of function.
Table 1.  Outline of the experiments, including behavioral treatment, timepoint(s) and
outcome measures of each.
Experiment 1:  Impact of
Contusion Injury on Biological
Outcomes
Experiment 2:  Impact of Uncontrollable
Shock on Biological Outcomes after SCI
Across Time
Experiment 3:  Impact of Morphine
Treatment During Uncontrollable
Shock on Biological Outcomes after
SCI
Experiment 4:  Impact of
Controllability on Biological
Outcomes after SCI
Behavioral Treatment
Anesthesia Alone
Laminectomy
Contusion Injury
Timepoint(s)
24 hr
Behavioral Treatment
Contusion Injury Unshocked
Contusion Injury Shocked
Timepoint(s)
6, 24, 72 hr and 7 d
Behavioral Treatment
Laminectomy Morphine Unshocked
Laminectomy Morphine Shocked
Contusion Injury Morphine Unshocked
Contusion Injury Morphine Shocked
Timepoint(s)
24 hr
Behavioral Treatment
Master
Yoked
Unshocked
Timepoint(s)
24 hr
Outcomes
BBB locomotor score
Spleen weight
Corticosterone
Norepinephrine
IL-! & IL-6
Outcomes
BBB locomotor score
Spleen weight
Corticosterone
Norepinephrine
 IL-! & IL-6
Outcomes
BBB locomotor score
Spleen weight
Corticosterone
Norepinephrine
IL-! & IL-6
Outcomes
BBB locomotor score
Spleen weight
Corticosterone
Norepinephrine
IL-! & IL-6
Immune cells at injury site
Electrolytes
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 The third experiment used morphine treatment to identify the relative
contribution of the physiological and psychological components to the biological
consequences of uncontrollable shock exposure. Given our previous findings, we predict
that morphine will have no effect on the consequences of uncontrollable shock.
Morphine may even potentiate these effects.
The last experiment evaluated the effect of stressor controllability on
corticosterone, norepinephrine, spleen weight, pro-inflammatory cytokine expression,
and immune cell populations following spinal cord injury.  Subjects given control over
the shock should look comparable to unshocked controls.  However, it is possible that
shock, independent of the degree of controllability, will affect some of the biological
outcomes measured.
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CHAPTER II
GENERAL METHOD
Subjects
Male, Sprague-Dawley rats obtained from Harlan (Houston, TX) served as
subjects.  Animals were approximately 100-120 days old and weighed between 300 and
350 grams.  Subjects were maintained on a 12-hour light-dark schedule and were housed
individually.  Food and water was available ad libitum.  Behavioral testing was
performed during the light portion of the cycle.
Surgery
Subjects received a contusion injury using the MASCIS device developed by
Gruner (1992) and Constantini and Young (1994).  Subjects were anesthetized with
isoflurane (2%).  Ten minutes later, spinal reflexes were assessed to verify that a stable
level of anesthesia had been achieved.  An area extending approximately 4.5 cm above
and below the injury site was shaved and disinfected with iodine.  A 7.0 cm incision was
made over the vertebral column.  Next, two incisions were made on either side of the
vertebral column, extending about 3.0 cm rostral and caudal to the T10-T11 segment.
The vertebrae dorsal and medial to T10-T11 were then cleared and the spinal tissue
exposed.  The vertebral column was fixed within the MASCIS device and a moderate
injury was produced by allowing the 10-g impactor (outfitted with a 3.0 mm tip) to drop
12.5 mm.  After injury, subjects were removed from the device, placed on a heating pad,
and the wound was closed with Michel clips.  To help prevent infection, subjects were
treated with 100,000 units/kg Pfizerpen (penicillin G potassium) immediately after
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surgery.  For the first 24 hours after surgery, rats were placed in a recovery room
maintained at 26.6°C.  To compensate for fluid loss, subjects received 2.5 mL of saline
after surgery.
Behavioral Procedures
Locomotor Recovery.  Locomotor recovery was assessed using the Basso,
Beattie, Bresnahan  (BBB) locomotor recovery scale (Basso, Beattie, Bresnahan, 1995).
All subjects were acclimated to the open-field testing apparatus (child’s swimming pool)
for 5 minutes, 3 days prior to surgery to prevent freezing behavior that often results from
a novel environment.  Care was taken to ensure that all investigators that scored
locomotor recovery had both high intra- and inter-rater reliability and were blind to the
treatment conditions.  The first test session occurred 24 hours after surgery, prior to any
experimental treatment.  Subsequent test sessions occurred daily.  Scores were
transformed according to the procedure described in Ferguson et al., 2004.
Uncontrollable Tailshock.  Subjects were loosely restrained in Plexiglas tubes as
previously described in Crown et al., 2002.  Intermittent constant current shock was
applied through electrodes taped to the tail.  Shocked rats received 80 ms tailshocks on a
variable time schedule with a mean of 2 seconds (range = 0.2-3.8 s) for six minutes.
Unshocked controls were placed in the restraining tubes, had the electrodes attached, but
did not receive shock.
Master/Yoke Paradigm.  Prior to training, the rat’s rear legs were shaved, marked
for placement of the shock leads, and a stainless steel wire was inserted over the tibia.
The subject was then placed in the test apparatus and secured by means of a wire belt.
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The contact electrode used to monitor leg position was taped to the plantar surface of the
rat’s foot using approximately 8-cm of porous tape (Orthaletic, 1.3 cm) with the end
positioned immediately distal to the plantar protuberance.  To minimize lateral leg
movements, a piece of porous tape was wrapped around the leg above the ankle and
taped to a bar extending across the apparatus directly under the front panel of restraining
tube.  The tape was adjusted so that it was taut enough to extend the knee, minimizing
variability in leg position while not interfering with the flexion response.  Next, a
stainless steel wire was inserted into the tibialis muscle, 1.7 cm above the first electrode,
and shock intensity adjusted to produce a 0.4 N flexion force (Grau, Barstow, & Joynes,
1998).  The container of salt solution, which measures 18 cm long x 10 cm wide x 5.5
cm deep, was placed under the contact electrode and the level of the solution was
adjusted so that the tip of the electrode was submerged by 4 mm.  A third of the subjects
(Master) then received 30minute of training with controllable shock.  For subjects in this
condition, shock only occurred when the contact electrode touched the underlying salt
solution.  A second group of subjects were experimentally yoked to the Master group.
Each yoked rat was coupled to a master subject and received legshock at the same time,
and for the same duration, as its master partner.  For the yoked subjects, shock was
uncontrollable—it occurred independent of leg position.  A third group of subjects
remained unshocked.
Master rats sometimes rapidly learn the instrumental requirement and, as a result,
receive relatively little shock exposure.  This could undermine both the potential benefit
of instrumental training and the negative consequences of uncontrollable shock.  To
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avoid this problem, the performance of the master subjects was closely monitored.  If a
master rat successfully performed the instrumental response, and received no shock, for
a period of 2 minutes during the first 10 minutes of testing, the response criteria was
increased by raising the water level.  Solution was added in 25 mL increments until it
touched the contact electrode.  This raised the water level by 4 mm.  A second day of
instrumental training (on the contralateral leg) was conducted after locomotor behavior
was scored on Day 2.  Subjects were prepared as described above and master rats
received an additional 30 minutes of training.  Yoked rats were again experimentally
coupled to their master partners and received shock independent of leg position.
Unshocked controls were set-up in the same fashion, but received no shock after the
contact electrode depth was adjusted.
Biological Assays
Blood Collection and Preparation.  Blood was drawn from the saphenous vein
into a heparinized microcentrifuge tube immediately following shock treatment in all
experiments. The samples were spun at 3000 x g for 15 minutes within 30 minutes of
collection and the plasma was transferred into a clean microcentrifuge tube and stored at
–20°C until further analysis.  Trunk blood was collected through cardiac puncture at the
time of sacrifice for all subjects.  Samples were collected into heparinized blood
collection tubes containing EDTA and were be spun at 3000 x g for 15 minutes within
30 minutes of collection.  Plasma was aliquoted into clean microcentrifuge tubes and
stored at –20°C until further analysis.  Three mls of whole blood were reserved for white
blood cell differential analysis and an electrolyte panel in Experiment 4.
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Tissue Collection and Preparation.  A 5 mm segment of spinal cord was
collected from the injury site, snap frozen in liquid nitrogen, and stored at –80 °C until
further analysis.  At the time of analysis, the tissue was thawed in T-per (Pierce,
Rockford, IL) containing protease inhibitor cocktail (Sigma, St. Louis, MO) and
homogenized in a microcentrifuge tube using a pestle.  Samples were then centrifuged at
4500 x g for 15 minutes at 4 °C and the supernatants were collected and stored at –80
°C.  Total protein concentrations were assessed using a BCA Protein Assay Kit (Pierce,
Rockford, IL) and spectrophotometer (Biomate 3, Thermo Electron Corporation,
Waltham, MA) according to the manufacturers instructions.  All tissue samples were
diluted to a final total protein concentration of 500 µg/ml using T-per.
Corticosterone Assessment.  Corticosterone levels were determined in all blood
samples using an ELISA (Correlate-EIA kit, Assay Designs, Ann Arbor, MI, sensitivity
= 26.99 pg/ml) following the manufacturer’s instructions.  Samples were read at a
wavelength of 405 nm using a microplate reader (Wallac Victor2 1420 Multilabel
Counter, PerkinElmer, Waltham, MA).
Norepinephrine Assessment.  Norepinephrine levels were determined in trunk
blood samples using an ELISA (Noradrenaline EIA, Rocky Mountain Diagnostics,
Colorado Springs, CO, sensitivity = 44 pg/ml) following the manufacturer’s instructions.
Samples were read at a wavelength of 450 nm using a microplate reader (Wallac Victor2
1420 Multilabel Counter, PerkinElmer, Waltham, MA).
Pro-inflammatory Cytokine Analysis.  The pro-inflammatory cytokines IL-1" and
IL-6 were analyzed in tissue homogenates using ELISA kits (BioSource, Carlsbad, CA,
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sensitivity < 3 and 8 pg/ml, respectively) according to the manufacturers instructions.
Samples were read at a wavelength of 450 nm using a microplate reader (Wallac Victor2
1420 Multilabel Counter, PerkinElmer, Waltham, MA).
White Blood Cell Differential Analysis and Electrolyte Panel.  A Celldyn 3500
automated cell counter (Abbott Laboratories, Abbott Park, IL) was used to analyze
lymphocytes and neutrophils in 1 ml of whole blood.  Results were expressed as number
of cells per ml of whole blood.  Sodium, potassium, chloride, and carbon dioxide levels
were also determined.
Data Analyses
Results were analyzed using an analysis of variance (ANOVA). In experiments
with a temporal variable (e.g., exposure duration, recovery period), trend analyses were
conducted to determine whether there is a significant linear (no inflection), quadratic
(one inflection) or cubic (two inflections) trend.  In cases where significant between
subject differences were obtained, group means were compared using the Duncan’s New
Multiple Range Test.  Locomotor scores were transformed to help assure that the data
was amendable to parametric analyses (Ferguson et al., 2004). Additional statistical
power was achieved by obtaining a measure of locomotor performance 24 hours after
injury, prior to experimental treatment.  This provided a behavioral index of the injury
extent that correlated with long-term recovery (r   0.41, p   0.05; Hook et al., 2004).  By
using this factor as a covariate in an analysis of covariance (ANCOVA), we substantially
reduce unexplained variance.   
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CHAPTER III
EXPERIMENT 1:  IMPACT OF CONTUSION INJURY
Others have shown that both corticosterone and pro-inflammatory cytokines are
increased following contusion injury (Popovich et al., 2001).  The purpose of this
experiment was to evaluate biological changes after contusion injury.
Method
Subjects (n=8) were assigned to one of three groups (anesthetized controls, sham,
and contusion) in this experiment.  Subjects received anesthesia alone, a laminectomy, or
a contusion injury and locomotor ability was assessed using the BBB scale 24 hours
later.  Subjects were then restrained for 6 minutes.  Blood was drawn from the saphenous
vein immediately following restraint and subjects were returned to their home cages.
Locomotor ability was re-assessed 24 hours later.  Subjects were then euthanized with
pentobarbital (100 mg/kg) and trunk blood was collected into a blood collection tube
containing EDTA. Plasma corticosterone and norepinephrine were determined using
ELISAs (Correlate-EIA kit, Assay Designs, Ann Arbor, MI, sensitivity = 26.99 pg/ml;
Rocky Mountain Diagnostics, Colorado Springs, CO, sensitivity = 44 pg/ml,
respectively).  At the time of sacrifice, a 5 mm segment of spinal cord was taken at the
injury site.  The tissue was snap frozen in liquid nitrogen and stored at –80 °C until
further analysis.  Tissue was homogenized as described in the methods section and total
protein concentration were assessed using a BCA Protein Assay Kit and
spectrophotometer.  All tissue samples were diluted with T-per as needed to obtain a
final total protein concentration of 500 µg/ml.  Tissue homogenates were assayed for the
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pro-inflammatory cytokines IL-1" and IL-6 using ELISA kits (BioSource, Carlsbad, CA,
sensitivity < 3 and 8 pg/ml, respectively) according to the manufacturers instructions.
Spleens were also retained and weighed at the time of sacrifice because stress has been
shown to impact spleen weights (Sumova & Jakoubek, 1989; Yamamotova et al., 2000).
Results
Locomotor Recovery.  BBB locomotor scores, which are depicted in Figure 1,
were recorded to ensure both adequate sham and contusion surgeries.  Anesthetized
controls and sham subjects had BBB scores of 12 (the highest converted score possible)
at both times tested, demonstrating that neither laminectomy, restraint or blood
collection affected locomotor ability.  Subjects that received a contusion injury had
scores of approximately 2.7 on both Day 1 and Day 2.  An ANOVA on BBB scores from
the last test session showed a significant effect of contusion injury, F(2, 21) = 82.36, p <
.05.  Post hoc comparisons of the group means revealed that only subjects that received a
contusion injury differed from the other groups, p < .05.  No other group differences
were significant, p > .05.
We also performed analyses on the unconverted BBB scores.  The reason for this
is because the transformation proposed by Ferguson et al. (2004) is based on the
assumption that subjects rarely exhibit BBB locomotor scores higher that 14.  This is
true for subjects that received a contusion injury but not the case for anesthetized
controls and shams that exhibited scores of 20 and higher.  Our analyses showed the
exact same pattern of results.  An ANOVA showed a significant effect of contusion
injury, F(2, 21) = 169.49, p < .05. Again, post hoc comparisons of the group means
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showed that only subjects that received a contusion injury differed from the other
groups, p < .05.  No other group differences were significant, p > .05.
Spleen Weights.  Figure 2 shows spleen weights across the three conditions.  To
control for any differences in body weight, subject’s weight at the time of sacrifice (last
day weight) was used as a covariate in this analysis.  An ANCOVA confirmed that there
were no group differences for spleen weights, F(2, 20) < 1.0, p > .05.
Corticosterone ELISA.  Corticosterone levels are shown in Figure 3.
Corticosterone in blood taken from the saphenous vein (leg blood) immediately after
restraint did not significantly vary across groups, F(2,21) = 2.47, p > .05.  There was
also no significant difference in corticosterone levels in blood collected at the time of
sacrifice (trunk blood), F(2,21) = 1.06, p > .05.
Figure 1.  The impact of receiving anesthesia alone, a laminectomy, or a contusion
injury on BBB locomotor scores.
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Figure 2.  Spleen weights of subjects that received anesthesia alone, a laminectomy, or
a contusion injury.
Figure 3.  Effects of anesthesia, a laminectomy, or a contusion injury on plasma
corticosterone levels immediately after restraint (left panel) and 24 hours after restraint
(right panel).
25
Norepinephrine ELISA.  Figure 4 shows norepinephrine levels.  Analysis of
norepinephrine levels in trunk blood also failed to produce any significant effects, F(2,
21) = 1.29, p > .05.
Pro-inflammatory Cytokine Analysis.  Results from the analyses of IL-1" and IL-
6 are illustrated in Figure 5.  An ANOVA showed that neither IL-1" nor IL-6
concentrations at the injury site varied across groups, both Fs < 1.42, p > .05.
Figure 4.  Plasma norepinephrine levels in subjects that received anesthesia alone, a
laminectomy, or a contusion injury.
Figure 5.  Impact of anesthesia alone, a laminectomy, or a contusion injury on IL-1"
and IL-6 protein levels at the injury site.
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Discussion
Experiment 1 showed that contusion injury has no impact on any of the
biological outcomes assessed at 24 hours, including corticosterone, norepinephrine, IL-
1", and IL-6 levels, and does not produce any significant changes in spleen weights.
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CHAPTER IV
EXPERIMENT 2:  IMPACT OF UNCONTROLLABLE SHOCK
Experiment 1 examined the impact of contusion injury on several common
biological outcomes. The following experiment was designed to assess the impact of
receiving uncontrollable shock following contusion injury on these same biological
outcomes.  These changes were initially assessed 24 hours following shock treatment but
then three additional timepoints were added.  Results from the 24 hour timepoint will be
presented first, followed by results across the four timepoints.
 Method
All subjects (n=8) received a contusion injury and locomotor ability was assessed
using the BBB scale 24 hours later.  Subjects then received 6 minutes of uncontrollable
tailshock or an equivalent amount of tube restraint.  Blood was drawn from the
saphenous vein immediately following shock treatment and subjects were returned to
their home cages.  Locomotor recovery was assessed once daily thereafter until the time
of sacrifice, 6, 24, 72, or 168 hours later.  On the final day of locomotor testing, subjects
were euthanized with pentobarbital (100 mg/kg) and blood and spinal cord tissue was
collected.  Corticosterone, norepinephrine, and pro-inflammatory cytokine levels were
then assessed using the procedures previously described in Experiment 1.  Spleens were
also retained and weighed at the time of sacrifice.
Results from the 24 hour Timepoint
Locomotor Recovery.  All results from the 24 hour timepoint are depicted in
Figure 6.  BBB locomotor recovery scores are shown in Figure 6A.  BBB scores were
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taken prior to any experimental treatment to ensure no pre-existing group differences.
An ANOVA on Day 1 BBB scores confirmed that the groups did not differ, F(1, 14) <
1.0, p > .05.  On the last test day, unshocked subjects tended to exhibit higher BBB
scores.  However, an ANCOVA, using Day 1 BBB as a covariate, failed to show a
significant effect of shock, F(1, 13) = 2.11, p > .05.
Spleen Weights.  Last day weight was used as a covariate in spleen weight
analysis to control for any variance in body weight.  As can be seen in Figure 6B,
uncontrollable shock caused a decrease in spleen weight.  An ANCOVA confirmed a
significant effect of shock, F(1, 13) = 6.11, p < .05.
Corticosterone ELISA.  Results from the corticosterone ELISA can be seen in
Figure 6C.  An ANOVA on corticosterone levels in blood taken immediately after shock
treatment failed to show any significant group differences, F(1, 14) < 1.0, p > .05. At 24
hours after shock treatment, shocked subjects exhibited higher level of corticosterone,
but this effect did not reach statistical significance, F(1, 14) = 3.51, p > .05.
Norepinephrine ELISA.  Figure 6D show the results from the norepinephrine
ELISA.  An ANOVA showed no significant group differences on this measure, F(1, 14)
= 1.17, p > .05.
Pro-inflammatory Cytokine Analysis.  IL-1" and IL-6 results can be seen in
Figures 6E and F, respectively.  Uncontrollable shock caused a significant increase in
IL-1" at the 24 hour timepoint, F(1, 14) = 5.59, p < .05 but had no effect on IL-6, F(1,
14) < 1.0, p > .05.
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Figure 6.  Effects of uncontrollable shock at 24 hours on BBB (A), spleen weight (B),
plasma corticosterone (C), plasma norepinephrine (D), and IL-1" (E) and IL-6 (F)
protein content at the injury site.
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Results Across Time
Locomotor Recovery.  BBB scores, which were taken prior to any experimental
treatment to ensure no pre-existing group differences, ranged from 3.56 (+ 0.89) to 5.00
(+ 0.91).  An ANOVA on Day 1 BBB scores confirmed no pre-existing group
differences, Fs < 1.0, p > .05. Figure 7 illustrates BBB scores from the last test sessions
across the four timepoints. As expected, all subjects showed an increase in BBB score
across time.  However, scores from the last test session were higher in the unshocked
subjects at all timepoints assessed.  An ANCOVA on last test session scores using Day 1
BBB scores as a covariate revealed significant main effects of shock and time, Fs >
12.27, p < .05.  Post hoc comparisons of the group means showed that unshocked
subjects differed significantly from shocked subjects at the 72 and 168 hour timepoints,
p < .05.
Figure 7.  Impact of uncontrollable shock on locomotor ability across time.
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Spleen Weights.  Again to control for any variance in body weight, last day
weight was used as a covariate in spleen weight analysis.  Overall, spleen weights from
shocked subjects were significantly lower than those of unshocked controls.  An
ANCOVA verified significant main effects of shock and time, Fs > 12.48, p < .05.  Post
hoc comparisons of the group means, which are displayed in Figure 8, showed that
spleen weights were significantly lower in shocked animals at the 24, 72, and 168 hour
timepoints, p < .05.
Corticosterone ELISA.  Because blood was collected from the leg immediately
after shock treatment in all subjects regardless of sacrifice timepoint, results from this
analysis were collapsed across the first three timepoints (Figure 9A).  There was not a
significant difference in corticosterone levels between unshocked and shocked subjects
in blood taken from the leg immediately after shock treatment, F(1, 46) < 1.0, p > .05. In
trunk blood, corticosterone levels were elevated in both shocked and unshocked subjects
Figure 8  The effects of uncontrollable shock on spleen weight in subjects sacrificed
6, 24, 72, and 168 hrs after shock treatment.
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at the 6 hour timepoint.  Post hoc comparisons of the group means showed that these
levels were significantly decreased in unshocked animals at all other timepoints, p < .05.
However, corticosterone levels remained elevated in the shocked subjects at all
timepoints tested (Figure 9B).  An ANOVA confirmed significant main effects of shock
and time, Fs > 4.07, p < .05.
Norepinephrine ELISA.  Norepinephrine results are depicted in Figure 10.  An
ANOVA failed to show any significant differences in norepinephrine levels in the blood
between shocked and unshocked subjects at any of the timepoints tested, Fs < 1.0, p >
.05.
Pro-inflammatory Cytokine Analysis.  IL-1" and IL-6 results are shown in Figure
11.  Overall, IL-1" levels decreased over the course of 168 hours.  An ANOVA on
results from the IL-1" ELISA revealed only a significant effect of time, F(1, 3) = 5.36, p
Figure 9.  Plasma corticosterone levels in shocked and unshocked subjects.  The left
panel depicts plasma levels immediately after shock treatment.  The right panel
shows plasma corticosterone levels at the time of sacrifice.
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< .05.  There was not a significant effect of uncontrollable shock on IL-1" levels at the
injury site across time.  For IL-6, uncontrollable shock caused a significant increase at
the 6 hour timepoint.  An ANOVA confirmed a significant main effect of time and a
significant Shock X Time interaction, Fs > 14.53, p < .05.  Further analysis of the
individual timepoints with a series of t-tests using a Bonferroni adjustment revealed that
unshocked subjects differed significantly from shocked subjects only at the 6 hour
timepoint, t(56) = 5.89, p < .05.
Figure 10 .  Plasma norepinephrine concentrations in shocked and unshocked subjects
across time.
Figure 11.  Impact of uncontrollable shock on IL-1" and IL-6 protein levels at the injury
site across time.
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Discussion
Uncontrollable shock caused a locomotor deficit that emerged within 72 hours
and persisted for up to 168 hours.  This locomotor deficit was accompanied by a
decrease in spleen weight within 24 hours.  This decrease in spleen weight also persisted
for up to 168 hours.  Uncontrollable shock also impacted many of the other biological
outcomes tested.  For example, both shocked and unshocked subjects had elevated levels
of corticosterone in trunk blood 6 hours after treatment.  These levels decreased in the
unshocked subjects within 24 hours but remained elevated throughout the 168 hours in
subjects that received shock.  Shocked subjects also had higher levels of the pro-
inflammatory cytokines IL-1" and IL-6 in tissue from the injury site.
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CHAPTER V
EXPERIMENT 3:  IMPACT OF MORPHINE
Uncontrollable shock is a stressor that consists of two components:  a
physiological component and a psychological component.  The relative role of these two
components in the detrimental effects of uncontrollable shock remains unknown.  We
have previously shown that morphine treatment, which blocks the psychological
experience of pain, does not affect the behavioral consequences of uncontrollable shock.
This suggests that the psychological component may play little role in our effect.  The
following experiments were designed to address this issue.
Method
Subjects (n=8) received either a contusion injury or laminectomy and locomotor
ability was assessed using the BBB scale 24 hours later.  Subjects then received
morphine (20 mg/kg; i.p.) and were given 6minutes of uncontrollable tailshock or an
equivalent amount of tube restraint thirty minutes later.  Laminectomy subjects were
used to assess the feasibility of using morphine during uncontrollable shock exposure in
rats with an intact spinal cord.  Our hope was that morphine would not interfere with the
behavioral or the biochemical consequences of uncontrollable shock in these subjects so
that it could be used to prevent the experience of pain in future experiments that require
laminectomy controls.   Blood was drawn from the saphenous vein immediately
following shock treatment and subjects were returned to their home cages. Locomotor
ability was re-assessed 24 hours later.  Subjects were then euthanized with pentobarbital
(100 mg/kg), blood and spinal cord tissue was collected and corticosterone,
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norepinephrine, and pro-inflammatory cytokine levels were assessed using the
procedures described in Experiment 1.
In order to compare the effect of morphine treatment versus no treatment on
locomotor recovery and biological indices of stress, shocked and unshocked subjects
from the 24 hour timepoint in Experiment 2 were used in all analyses.  The procedure
used in these subjects was identical to that used in the current experiment with the
exception of morphine treatment.
Results
Locomotor Recovery.  BBB scores for Days 1 and 2 are depicted in Figure 12.
Figure 12A shows the scores for all subjects that received morphine.  Figure 12B shows
the scores for all subjects that received a contusion injury.  An ANOVA confirmed a
significant main effect of injury for subjects that received morphine, F(1, 28) = 1.60, p <
.05.  All subjects that received a laminectomy had BBB scores of 20 or higher,
indicating that little to no spinal cord damaged occurred. For contused subjects, an
ANOVA showed no group differences on Day 1 BBB scores for subjects that received
contusion injury, Fs < 1.0, p > .05.
In morphine-treated subjects, an ANCOVA revealed significant main effects of
injury and shock, Fs > 4.13, p < .05.  Post hoc comparisons showed that uncontrollable
shock only caused a significant decrease in BBB scores in contused subjects, p < .05.
The fact that uncontrollable shock had no impact on locomotor scores in laminectomy
subjects suggests that shock only produces detrimental effects in the presence of a
contusion injury.  In contused subjects, uncontrollable shock caused a significant
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Figure 12.  The effect of receiving morphine treatment during uncontrollable shock on
BBB locomotor scores.  Figure 12A shows the results from all morphine-treated
subjects and Figure 12B depicts those from all contused subjects.  The left panels
show BBB scores prior to any experimental treatment.  The right panels show BBB
scores 24 hours after shock exposure.
decrease in BBB scores in morphine-treated subjects and subjects that received no
treatment.  An ANCOVA using Day 1 BBB as a covariate confirmed a significant main
effect of shock, F(1, 27) = 4.60, p < .05.
Spleen Weights.  Spleen weights are shown in Figure 13, with morphine-treated
subjects in Figure 13A and contused subjects in Figure 13B.  Subject’s last day weights
were again used as a covariate in all analyses.  An ANCOVA on spleen weights from all
morphine-treated subjects revealed no significant effects, Fs < 1.05, p > .05.  In contused
subjects, uncontrollable shock caused a decrease in spleen weights.  An ANCOVA
showed a significant main effect of shock, F(1, 27) = 4.50, p < .05.  Post hoc analysis
demonstrated that subjects that did not receive morphine and remained unshocked were
significantly different than unshocked subjects that received morphine and shocked
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Figure 14.  Plasma corticosterone levels in all morphine-treated (top graphs) and
contused subjects (bottom graphs).  Figures 14 A&C represent corticosterone levels
immediately after shock treatment and Figures 14B&D show those 24 hours after
shock.
subjects that did not receive morphine, p < .05.  No other group differences were
significant, p > .05.
Figure 13.  The impact of receiving morphine treatment during uncontrollable shock on
spleen weight.  Figure 13A shows the results from all morphine-treated subjects and
Figure 13B depicts those from all contused subjects.
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Corticosterone ELISA.  Figure 14 depicts the impact of shock and morphine
treatment on corticosterone levels.  Figure 14A shows the data for the blood collected
from the leg immediately after shock treatment in all morphine-treated subjects and
Figure 14C shows the same for all contused subjects.  No significant effects were found
for corticosterone levels in blood collected immediately after shock treatment in the
comparison of all morphine-treated subjects, Fs < 3.80, p > .05.  There was, however, a
significant main effect of drug among contused subjects, F(1,28) = 12.79, p < .05.  In
general, morphine caused an increase in corticosterone.  Post hoc analysis of the group
means showed that morphine-treated subjects that received uncontrollable shock were
significantly different than both saline groups, p < .05.  No other group differences
reached significance, p > .05.
Figure 14B illustrates the results of the corticosterone analysis from trunk blood
in morphine-treated subjects.  Figure 14D shows that for all the subjects that received a
contusion injury.  Uncontrollable shock caused an increase in corticosterone among all
subjects that received morphine.  A two-way ANOVA revealed only a significant main
effect of shock, F(1,28) = 4.18, p < .05.  Post hoc comparisons of the group means
showed that contused subjects that received shock after morphine-treatment differed
significantly from subjects that received a laminectomy and no shock after morphine
treatment, p < .05.  No other significant group differences were noted among all
morphine-treated subjects, p > .05.  In contused subjects, both uncontrollable shock and
morphine caused an elevation in corticosterone.  A two-way ANOVA showed
significant main effects of both shock and drug, Fs > 6.42, p < .05.  Post hoc
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comparisons showed that both morphine groups (shocked and unshocked) had
significantly higher corticosterone levels than both saline groups, p < .05.  There were no
other significant group differences, p > .05.
Norepinephrine ELISA.  Norepinephrine levels are shown in Figure 15.  Figure
15A illustrates those in all morphine-treated subjects and Figure 15B shows those for all
contused subjects.  No significant group differences were noted among either morphine-
treated subjects, Fs < 2.60, p > .05 or contused subjects, Fs < 1.76, p > .05.
Pro-inflammatory cytokine ELISAs.  Figure 16 shows the results from the
analyses of the pro-inflammatory cytokines IL-1" and IL-6 at the injury site in
morphine-treated subjects (Figure 16A & C) and contused subjects (Figure 16B and D).
Among morphine-treated subjects, contused subjects had lower levels of IL-1" than
subjects that received only a laminectomy and this effect occurred independent of shock
treatment.  An ANOVA showed a significant main effect of injury, F(1,28) = 35.20, p <
Figure 15.  Norepinephrine levels in plasma for all morphine-treated (A) and all
contused subjects (B).
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.05.  Post hoc comparisons showed that both contused subjects that did not receive shock
and those that did receive shock differed significantly from both laminectomy groups, p
< .05.  No other comparisons reached significance, p > .05.  Similar results were noted
for IL-6 among morphine-treated subjects.  Again, contused subjects had lower levels of
IL-6 than subjects that received laminectomy alone.  An ANOVA confirmed a
significant main effect of injury, F(1,28) = 6.76, p < .05.  Post hoc comparisons of the
group means showed that subjects that received a laminectomy (shams) and shock were
significantly different from both contusion groups, p < .05.  No other group differences
were significant, p > .05.
Figure 16.  Impact of receiving morphine during uncontrollable shock on IL-1" and
IL-6 protein levels at the injury site.  Figures 16 A&C show the results for all
morphine-treated subjects and Figures 16B&D show those for contused subjects.
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In contused subjects, morphine caused a significant increase in IL-" independent
of shock treatment.  An ANOVA confirmed a significant main effect of drug, F(1,28) =
48.57, p < .05.  Post hoc comparisons revealed that both morphine groups differed
significantly from both saline groups, p < .05.  No other significant group differences
were found, p > .05.   A similar pattern of results emerged for IL-6, with morphine
causing an increase in IL-6 that was again independent of shock treatment.  An ANOVA
showed that there was a significant main effect of drug, F(1,28) = 4.15, p < .05.  Post
hoc analysis of the group means confirmed that unshocked subjects that received
morphine had significantly higher IL-6 levels than shocked subjects that received no
treatment, p < .05.  No other group differences reached significance, p > .05.
Discussion
In the current experiment, uncontrollable shock produced a locomotor deficit
only in contused subjects and morphine did not attenuate this effect. Several biological
changes also occurred within 24 hours of shock treatment.  Uncontrollable shock caused
a decrease in spleen weights and increase in corticosterone in contused subjects.  Again,
morphine treatment failed to attenuate these effects.  Instead, morphine often
exacerbated or produced changes that were independent of shock treatment.  For
example, morphine caused dramatic increases of corticosterone and IL-1" and a
significant increase of IL-6 in contused subjects.
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CHAPTER VI
EXPERIMENT 4:  IMPACT OF CONTROLLABILITY
Controllability has been shown to be a factor in whether a stressor has negative
effects.  For the most part, control is a good thing.  We have shown that if subjects have
control over shock exposure, shock has no effect on locomotor recovery.  However,
controllability typically does not prevent the biological consequences of exposure to
shock, such as overall increases in corticosterone.  The following experiments were
designed to determine the impact of receiving controllable versus uncontrollable shock
after spinal cord injury on corticosterone, norepinephrine, pro-inflammatory cytokines,
and immune cell populations.
Methods
Subjects (n=8) received a contusion injury and locomotor ability was assessed
using the BBB scale 24 hours later.  Subjects were then exposed to the master/yoke
paradigm as described in the methods.  This involved two days of training.  Locomotor
ability was re-assessed 24 hours after the last training session and subjects were
euthanized with pentobarbital (100 mg/kg).  Blood and spinal cord tissue was collected
and corticosterone, norepinephrine, and pro-inflammatory cytokine levels were assessed
using the procedure described in Experiment 1. Approximately 2 ml of whole blood was
retained from the trunk blood and white blood cell differential analysis and an electrolyte
panel was performed as described in the methods.
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Results
Instrumental Training.  Analysis of response durations from Day 1 and Day 2
showed that there was not a significant difference across days, allowing us to collapse
the two days for further analysis. Performance during the instrumental training
procedure for master and yoked subjects is depicted in Figure 17.  Response durations
and response numbers from Days 1 and 2 have been collapsed across the two days.
Figure 17.   Response durations (A) and response numbers (B) during instrumental
training with controllable (Master) and uncontrollable (Yoked) shock across time.  The
results from Days 1 & 2 of training have been collapsed.  Mean response durations and
response numbers are shown in the right panels (B & D, respectively).
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Response duration and response number across time are illustrated in Figures 17A & C,
respectively.  Mean response duration and response number collapsed across time are
shown in Figures 17B & D, respectively. An ANOVA showed that neither day nor its
interaction with shock or session time approached significance, Fs < 3.37, p > .05.  As
expected, master subjects exhibited an increase in response duration, indicative of
learning, over time, whereas yoked subjects did not.  An ANOVA on mean response
durations showed a significant difference between master and yoked subjects, F(1,12) =
6.78, p < .05.  There was also a significant main effect of time and a Time X Group
interaction, both Fs > 1.55, p < .05.
For response number, an ANOVA confirmed only a significant main effect of
group, F(1,12) = 6.78, p < .05.  On average, master subjects made more responses than
their yoked partners.  This resulted from yoked rats habituating to the shock and,
therefore making fewer responses.
Locomotor Recovery.  Figure 18 illustrates the impact of controllable versus
uncontrollable shock on locomotor recovery. An ANOVA confirmed no pre-existing
group differences on Day 1 BBB scores, F(2,18) < 1.0 , p > .05.  Master subjects that
received controllable shock showed an increase in BBB scores over the two days of
locomotor testing, whereas yoked and unshocked subjects did not.  An ANCOVA using
Day 1 BBB score as the covariate, showed a significant main effect of group, F(2,17) =
3.48, p < .05.  Post hoc comparison of the group means showed that master subjects had
significantly higher BBB scores than both yoked subjects and unshocked controls across
the two days, p < .05.
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Spleen Weights.  Spleen weights across the three groups are shown in Figure 19.
No significant differences in spleen weights were found, F(2,18) = 1.10, p > .05.
Figure 18.  BBB locomotor scores from master, yoked, and unshocked subjects across
the three days of testing.
Figure 19.  Impact of controllability on spleen weights 24 hours following the last
instrumental training session.
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Corticosterone ELISA.  Figure 20 depicts corticosterone levels in trunk blood
among master, yoked, and unshocked subjects.  Interestingly, unshocked controls
exhibited the highest level of corticosterone.  An ANOVA confirmed a significant effect
of group, F(2,18) = 5.44, p < .05.  Post hoc analysis among the three groups showed that
unshocked subjects had significantly higher corticosterone levels than both master and
yoked subjects.  This will be addressed later in the discussion section.
Norepinephrine ELISA.  Figure 21 shows the impact of controllable versus
uncontrollable shock on norepinephrine levels in trunk blood.  Although master subjects
appeared to have higher levels of norepinephrine, an ANOVA failed to find any
significant effects, F(2,18) = 1.62, p > .05.
Pro-inflammatory Cytokine Analysis.  The results from the IL-1" and IL-6
ELISAs are shown in Figure 22.  There were no significant differences across groups for
IL-1 ", F(2,18) = 1.29, p > .05.  However, unshocked subjects had significantly higher
Figure 20.  Plasma corticosterone levels in master, yoked, and unshocked subjects 24
hours after the last instrumental training session.
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levels of IL-6 than both master and yoked subjects, F(2,18) = 3.90, p < .05.  Post hoc
analysis confirmed that this effect was significant, p < .05.
White Blood Cell Differential Analysis.  The impact of controllable and
uncontrollable shock on the number of neutrophils, lymphocytes, monocytes and
Figure 21.  Impact of controllability on plasma norepinephrine levels 24 hours
following the last instrumental training session.
Figure 22.  IL-1" and IL-6 protein levels at the injury site for master, yoked, and
unshocked subjects.  Protein content was analyzed 24 hours after the last training
session.
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eosinophils in the blood are depicted in Figure 23.  No group differences were found for
neutrophils, lymphocytes, or eosinophils, Fs < 1.31, p > .05.  An ANOVA on blood
monocytes showed a significant effect of shock, F(2,18) = 3.63, p < .05.  Post hoc
comparison of the group means showed that unshocked subjects had a significantly
higher number of monocytes than master subjects.  The reasons for this are unknown.
Electrolyte Panel.  The results from the electrolyte panel are displayed in Figure
24.  Sodium, potassium, chloride, and carbon dioxide levels were assessed.  No group
differences were noted for any of these electrolytes, Fs < 1.38, p > .05.
Figure 23.  The effects of controllability on blood neutrophils, lymphocytes, monocytes
and eosinophils 24 hours following the last training session.
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Discussion
Experiment 4 produced some interesting and unexpected results.  For example,
controllable shock led to an increase in BBB locomotor scores but had no significant
effect on any of the other biological outcomes assessed.  Surprisingly, unshocked
subjects exhibited higher corticosterone levels than both master and yoked subjects and
this increase in corticosterone was accompanied by an increase in IL-6 in tissue from the
injury site and an increase in the number of monocytes within the blood.
Figure 24.  Results from the electrolyte panel for master, yoked, and unshocked
subjects.  Blood was analyzed 24 hours after the last instrumental training session.
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CHAPTER VII
SUMMARY AND GENERAL DISCUSSION
Impact of Contusion Injury
The amount and extent of secondary damage that occurs following spinal cord
injury determines the amount of function retained.  Many treatment strategies are
therefore aimed at limiting the processes that contribute to secondary damage.  Among
these processes are vascular, biochemical, inflammatory, cellular, and molecular events.
Factors that exacerbate these processes, like stress, may worsen functional outcome after
injury.  Thus, it is essential to understand how stress affects these processes.  The current
experiments begin to address this issue.  Experiment 1 showed how contusion injury
itself causes changes in several biological indices of stress including, corticosterone and
norepinephrine levels, changes in spleen weight, and expression of the pro-inflammatory
cytokines, IL-1" and IL-6.  Three groups were used in this experiment to systematically
address how contusion injury impacts these processes.  They included anesthetized
controls, subjects that only received a laminectomy (shams), and contused subjects.
Overall, no differences were found among these groups for any of the indices assessed.
Very few studies have examined the impact of spinal cord injury itself on
measures commonly used to assess the stress response, including changes in
corticosterone and norepinephrine.  To my knowledge, only one study by Popovich et al.
(2001) has looked at the impact of contusion injury on corticosterone levels.  In this
study, they used a similar contusion model and had treatment groups comparable to the
ones used here#anesthetized controls, laminectomy group, and contused group.  They
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found that corticosterone levels were significantly higher in subjects that received a
contusion injury 1 day postinjury.  However, by 3 days postinjury, corticosterone levels
were not significantly higher than those from the laminectomy group.  In Experiment 1,
corticosterone levels were assessed 24 hours after injury in blood collected from the leg
and again at 48 hours after injury when subjects were sacrificed.  However, no
differences were found at either timepoint.  This discrepancy in findings may result from
differences in sex and strain of rats used in the two studies.  Female, Lewis rats were
used in the Popovich study, whereas male, Sprague-Dawley rats were used in the current
study.  Several studies have demonstrated both sex and strain differences in
corticosterone responses to stress, with females typically exhibiting a much more
pronounced response (Chisari et al., 1995; Faraday et al., 2005).
Studies focusing on the impact of spinal cord injury on norepinephrine have
generally assessed changes in norepinephrine at the injury site.  Most of these studies
have shown little or no significant changes in norepinephrine levels at the injury site
(Naftchi et al., 1974; Rawe et al., 1977).  Although norepinephrine levels were assessed
in blood plasma in the current study, we also observed no significant changes.
Unlike corticosterone and norepinephrine, there have been a number of studies
assessing the expression of pro-inflammatory cytokines after spinal cord injury.  For the
most part, these studies have shown significant increases in IL-1" and IL-6 at the injury
site that emerge and peak within 6 to 12 hours (Hostettler & Carlson, 2002; Nesic et al.,
2001; Nakamura et al., 2003; Wang et al., 1997, 2005).  Typically, levels return to
normal within 48 hours.  Thus, it is not surprising that no effects were found in
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Experiment 1, in which IL-1" and IL-6 levels at the injury site were not assessed until 48
hours after injury.  Analyses at an earlier timepoint may reveal a different pattern of
results.
Impact of Uncontrollable Shock
Uncontrollable shock was used as a stressor in Experiments 2-4 to determine
how stress impacts several biological outcomes following spinal cord injury.  Changes in
spleen weight, corticosterone, and norepinephrine, which are known to change in
response to stress, were measured to establish whether uncontrollable shock induces a
stress response.  We found that uncontrollable shock did produce a stress response
characterized by a decrease in spleen weight and increases in corticosterone.  These
effects emerged within 24 hours and persisted for up to 7 days.  These findings are in
line with others, which have shown that stressors, particularly uncontrollable ones,
produce similar effects (LeMay et al., 1990; Nguyen et al., 1998; O’Connor et al., 2003;
Sumova & Jakoubek, 1989; Turnbull et al., 1994; Yamamotova et al., 2000; Zhou et al.,
1993).  In one study, footshocks, were used in a model of anticipation stress (Sumova &
Jakoubek, 1989).  Rats received footshocks over the course of 8 days.  On the 9th day,
they were placed in the chamber for 15 minutes but did not receive any shock.  Spleen
weight and corticosterone levels were assessed immediately thereafter. Subjects given
footshocks had smaller spleens and exhibited higher corticosterone levels.  Interestingly,
these researchers showed that naloxone pre-treatment potentiated the decrease in spleen
weight suggesting that the opioid system may preserve or protect the spleen from the
consequences of stress.  Naloxone, however, had no effect on changes in corticosterone.
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Their finding that naloxone potentiated the reduction in spleen weight suggests that
morphine pre-treatment may attenuate this effect.  However, we found that morphine
had no effect on the decrease in spleen weight observed after uncontrollable shock.  In
fact, morphine itself caused a reduction in spleen weight in unshocked subjects (Figure
13B).  Because morphine is a µ-opioid receptor agonist, our findings imply that an
opioid receptor system other than the µ opioid receptor system is involved in the
preservation and/or protection of the spleen during stress.
Although uncontrollable shock impacted both spleen weights and corticosterone
levels, it had no effect on plasma norepinephrine.  This is surprising given that this
neurotransmitter has been heavily implicated in the behavioral deficit in learned
helplessness.  Weiss and colleagues (1976) developed a neurochemical model that
centered on norepinephrine as the primary candidate to account for the behavioral effects
observed after uncontrollable shock.  They maintained that exposure to uncontrollable
shock led to a dysfunctional noradrenergic system, resulting partially from depletion of
norepinephrine in limbic brain areas.  Motor behavior in animals subjected to
uncontrollable shock would be reduced as a result of this depletion, causing the animals
to respond less to their environment.  It is important to note that it is not the shock per se
that disrupts the noradrenergic system, but rather the uncontrollable aspect of the shock
that produces the deficit.  Subjects given control over the shock do not exhibit any
changes in noradrenergic function (Weiss et al., 1980).
Here we showed that plasma norepinephrine was not elevated at any of the
timepoints assessed.  These results may have emerged because we failed to assess
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norepinephrine at an early enough timepoint following shock treatment.  For example,
others have shown that uncontrollable shock causes an increase in plasma
norepinephrine, but this effect is transient, lasting less than 30 minutes after shock
termination (Swenson & Vogel, 1983; Weyers, Bower, & Vogel, 1989).  The earliest
timepoint examined in the current experiment was 6 hours after shock exposure.
Examination at an earlier timepoint may show increases in plasma norepinephrine.
Furthermore, this transient increase in plasma norepinephrine is often associated with a
subsequent decrease in brain norepinephrine.  Uncontrollable shock typically causes a
decrease in norepinephrine in regions such as the locus coeruleus, hypothalamus, and
hippocampus that is accompanied by an increase in its metabolite, 3-meth-oxy-4-
hydroxy-phenylethylene glycol sulfate (MHPG-SO4; Anisman et al., 1987; Heinsbroek
et al., 1991; Lehnert et al., 1984; Swenson & Vogel, 1983; Weiss et al., 1980). We did
not examine norepinephrine content in the brain, thus future studies are warranted to
determine whether our shock procedure produces similar effects.
Impact of Morphine
Experiment 3 used morphine to determine the effect of eliminating the
psychological experience of pain caused by uncontrollable shock.  Previous work from
our laboratory showed that morphine did not prevent the consequences of uncontrollable
shock, but rather exacerbated its effect on some measures of recovery, including sensory
function and lesion size (Hook et al., 2007).  Here, we show that morphine again did not
attenuate the effects of uncontrollable shock in contused subjects.  Morphine treatment
failed to prevent the impairment of locomotor recovery, the decrease in spleen weight,
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and the increase in corticosterone that results from shock exposure. In some cases
morphine potentiated these responses and even caused similar changes in the absence of
uncontrollable shock.  For example, like uncontrollable shock, it caused a significant
increase in corticosterone, IL-1" and IL-6.  These results are consistent with those from
other studies, which have shown that comparable doses of morphine increase plasma
corticosterone within 1 hour (Budziszewska et al., 1999; Laorden & Milanes, 1999;
Mellon & Bayer, 2001; Milanes et al., 1993; Simon et al., 1975).  Our work suggests that
plasma corticosterone levels stay elevated for up to 24 hours after morphine treatment.
Morphine also elevates circulating levels of both IL-1" and IL-6 (Bertolucci,
Perego, & Simoni, 1996; Johnston et al., 2004; Houghtling & Bayer, 2002; Houghtling
et al., 2000).  Upregulations of IL-1" and IL-6 mRNAs, as well as protein levels, have
also been demonstrated in the brain and spinal cord (Johnston et al., 2004; Zubelewicz et
al., 1999).  The mechanism underlying this effect remains largely unknown; however, it
requires an intact adrenal cortex because morphine does not increase IL-6 in
adrenalectomized animals (Houghtling & Bayer, 2002; Houghtling et al., 2000).
Corticosterone may play a role because increases in IL-6 are often accompanied by
increases in corticosterone (Houghtling & Bayer, 2002), as was the case in the current
study.  However, this correlation does not address the directionality of the effect.  The
corticosterone response may drive the IL-6 response or vice versa.  Evidence exists for
both hypotheses.  For example, IL-6 is known to activate the HPA axis, causing the
release of corticosterone (Lenczowski et al., 1999).  On the other hand, increases in
corticosterone are believed to precede the elevation in IL-6 (Houghtling & Bayer, 2002).
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Still other evidence suggests that the increase in corticosterone is independent of IL-6
elevation (Houghtling & Bayer, 2002; Ray, LaForge, & Sehgal, 1990).
The morphine-induced increase of IL-1" and IL-6 at the injury site suggests that
morphine treatment, like shock, causes an elevation of activated microglia and
macrophages in the spinal cord.  This finding contradicts other studies, which have
shown that, in general, morphine suppresses immune function.  For example, morphine
has been shown to inhibit chemotaxis in monocytes (Perez-Castrillon et al., 1992;
Stefano et al., 1993), microglia (Chao et al., 1997) and granulocytes (Makman, Bilfinger,
& Stefano, 1995).  Morphine treatment also decreases natural killer (NK) cell activity
(Hoffman et al., 1995; Mellon & Bayer, 2001; Shavit et al., 1986; Weber & Pert, 1989),
decreases blood lymphocyte proliferation (Fecho et al., 1996; Hoffman et al., 1995;
Houghtling et al., 2000; Mellon & Bayer, 1998, 2001), reduces polymorphonuclear cell
activity, and decreases the number of phagocytic cells, as well as, suppresses phagocytic
activity (Tubaro et al., 1987).  Acute morphine treatment also affects more sophisticated
immune responses such as antibody production (Jankovic & Radulovic, 1992; Veljic et
al., 1992).  The exact mechanism through which these effects are mediated remains
unknown, although both the autonomic nervous system and the HPA axis have been
implicated (Fecho et al., 1996; Flores, Dretchen, & Bayer, 1996; Mellon & Bayer,
2001).  Further studies will be needed to determine if morphine enhances or suppresses
immune function in our spinal cord injury model.  Regardless, the finding that morphine
increases corticosterone and pro-inflammatory cytokines expression at the injury site has
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important clinical implications because it suggests that a routinely used clinical
treatment could contribute to secondary damage after spinal cord injury.
Impact of Controllability
The last experiment determined if controllability could prevent the consequences
of shock.  Experiment 4 failed to show any significant differences between master and
yoked subjects on any of the biological variables tested.  Unshocked subjects, however,
exhibited higher corticosterone than both master and yoked subjects and this increase
was accompanied by an increase in IL-6 at the injury site and monocytes in the blood.
These results are puzzling given our previous findings in unshocked controls.  However,
it should be noted that the procedure used in this experiment differed from that used in
the previous experiments.  For example, tailshock was used previously to administer
uncontrollable shock, whereas legshock was used in the current experiment.  Another
difference concerns the amount of time the unshocked subjects were restrained in the
tube.  Subjects in Experiments 2 & 3 only experienced 6 minutes of restraint, whereas
subjects in Experiment 4 were restrained for 30 minutes for two consecutive days.  There
were also differences in how these subjects were restrained.  Subjects in Experiment 4
were retrained in tubes that allowed their hindlimbs to hang freely and accordingly have
to be secured using a wire belt in.  The tubes used in the other experiments provided a
flat surface on which the subject could lay and have barriers at the end to prevent escape;
a wire belt was not required.  These differences in procedure may help to explain why
unshocked subjects had high corticosterone levels.  They do not, however, explain why
unshocked subjects, that received the exact same treatment as the master and yoked
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subjects with the exception of extensive shock exposure, differed significantly from
these two groups.  Future studies will be needed to resolve these issues.  One solution is
to include a home cage control to assess the impact of the restraint that is included in the
paradigm.
Mechanism
Figure 25 outlines a model that illustrates how exposure to uncontrollable shock
may lead to impaired recovery of function. In this model, which is a modified version of
that proposed by Griffis et al. (2006), nociceptive input caused by uncontrollable
tailshock activates nociceptors, which relay the pain signal to the spinal cord through A-
delta and C peripheral nerve fibers (Cousins & Power, 1999; Soledad Cepeda & Carr,
1996).  The signal is then projected to the brainstem reticular formation through
ascending pain pathways like the spinothalamic tract and on to the hypothalamus and
locus coeruleus to activate the stress axes (Soledad Cepeda et al., 1996; Yaksh, 1999).
Projections to the limbic structures induce the negative emotions, like fear and anxiety,
which are associated with pain.  The limbic and forebrain areas initiate descending
inhibitory signals, which originate in the periaqueductal gray (PAG) project to the rostral
ventro-medial medulla (RVM) and to the dorsal horn of the spinal cord.  These
descending signals cause the release of endogenous opioids, serotonin, and
norepinephrine that decrease the nociceptive input (Pasero, Paice, & McCaffery, 1999).
Activation of the HPA and sympatho-adreno-medullary stress axes also causes the
release of other endogenous opioids that modulate the pain signal at both the brain and
spinal cord level (Fields & Basbaum, 1999; Soledad et al., 1996).
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Figure 25.  Outlines two mechanisms through which uncontrollable shock may
contribute to cell loss and loss of recovery of function.  Uncontrollable shock
activated nociceptors, which in turn activate A-delta and C fibers.  These peripheral
nerve fibers transmit the signal to the spinal cord where it is relayed to the brain via
the spinothalamic tract.  The signal travels through the brain stem to the midbrain up
to thalamus and cortex.  Activation of limbic structures cause descending inhibitory
signals to be sent to the dorsal horns of the spinal cord.  Activation of the
hypothalamus causes the release of corticosterone into the bloodstream.
Corticosterone travels to the spinal cord where it enhances glutamatergic
neurotransmission and excitotoxicity that results in cell loss in the spinal cord (red
arrow).  Activation of the nucleus tractus solitarius (NTS), hypothalamus, and
cortical areas results in the release of pro-inflammatory cytokines, which stimulate
macrophages and enhance leukocyte migration to the spinal cord, resulting in
potentiation of secondary damage (purple arrow).  Adapted version of a figure that
appears on Sigma-Aldrich.com.
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The model contains two separate pathways through which shock may produce its effects.
The first involves activation of the HPA axis and subsequent release of corticosterone
(red box and arrows).  It is well recognized that many types of stressors cause an
increase in glucocorticoids, like corticosterone, that can have both direct and indirect,
modulatory effects on other systems.  These effects can be beneficial in some cases but
detrimental in others.  For example, glucocorticoids have been shown to both enhance
and impair learning and memory processes (For a review see Sapolsky, 2003).
Moderate, short-lived increases are correlated with beneficial effects of glucocorticoids,
whereas high, prolonged increases are associated with negative effects.  Uncontrollable
shock caused a prolonged increase in corticosterone in the current study that was
associated with an impairment of locomotor function.  This loss of motor function may
have resulted as a direct consequence of corticosterone potentiating excitoxicity within
the spinal cord.  The physical and psychological component of uncontrollable shock
would cause activation, and possibly dysregulation, of the HPA axis, which in turn
results in the release of corticosterone.  Corticosterone has been shown to enhance
glutamatergic neurotransmission in the hippocampus by increasing extracellular
excitatory amino acid concentrations (Lowy, Gault, & Yamamoto, 1993; Virgin et al.,
1991) and potentiating NMDA receptor function (Bartanusz et al., 1995; Krugers et al.,
1993; Mulholland et al., 2006; Takahashi et al., 2002; Weiland, Orchinik, & Tanapat,
1997).  In the presence of injury, these effects contribute to excitoxicity and exacerbate
cell loss that can attenuate recovery of function.  A similar effect may be observed in the
spinal cord, which also contains glucocorticoid receptors (Cintra, Molander, & Fuxe,
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1993; Clark, Maclusky, & Naftolin, 1981; Takasaki et al., 2005).  Furthermore,
corticosterone-induced activation of the NMDA receptor may also lead to microglia
proliferation and the release of pro-inflammatory cytokines within the spinal cord.  Nair
and Bonneau (2006) showed that four days of restraint stress induced proliferation of
microglia in the brain.  They concluded that this effect was a result of corticosterone-
induced activation of the NMDA receptor because the effect was reversed by blocking
corticosterone synthesis, glucocorticoid receptors, and NMDA receptors.  Their work
suggests that stress-induced release of corticosterone can activate microglia, resulting in
a pro-inflammatory response within the CNS that could potentiate inflammatory
conditions.  Potentiation of the inflammatory response after spinal cord injury could
contribute to secondary damage and greater loss of function.
The other mechanism through which uncontrollable shock may disrupt recovery
of function is illustrated in purple in Figure 25.  In addition to activating the stress axes,
uncontrollable shock is also believed to activate pathways associated with “sickness
behavior”, resulting in increases in IL-1" and a potentiated immune response.  Maier and
Watkins (1998) suggest that the nociceptive signal enters into the central immune
activation, or sickness behavior, pathway in the brainstem.  The signal travels through
the brainstem to the nucleus tractus solitarius (NTS), hypothalamus, and cortical areas to
induce the release of pro-inflammatory cytokines by macrophages and other immune
cells.  Pro-inflammatory cytokines then activate receptors on leukocytes and endothelial
cells to increase cell adhesion molecule (CAM) expression, and thereby enhance
leukocyte migration to areas of inflammation (Dinarello, 2003; Wang, Czura, & Tracey,
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2003).  The process by which leukocytes and lymphocytes are trafficked to areas of
tissue damage and inflammation has been well characterized and involves four steps
(Butcher, 1991; Springer, 1994).  The first of which is called “rolling” and involves
formation of weak bonds between endothelial CAMs, which are expressed in response to
trauma, infection, and hormones, and CAMs on leukocytes.  In this process, leukocytes
roll end over end through the blood, repeatedly breaking the CAM bonds.  Step 2,
referred to as “activation,” occurs when leukocytes are exposed to chemokines such as
IL-8 and macrophage inflammatory protein that bind receptors on their cell surface,
causing a phenotype switch into an activated leukocyte.  Integrins on the cell surface
undergo a confirmational change that fosters stronger bonds.  “Tethering” occurs in Step
3 when these integrins form strong bonds with endothelial CAMs, stabilizing their
proximity to the endothelial surface.  At the same time, inflammatory mediators that
increase vascular permeability are released.  Extravasation then occurs as the leukocyte
moves from the blood vessel to the tissue.  In the process, they become activated,
differentiated effector cells capable of producing chemokines, pro-inflammatory
cytokines and other mediators that exacerbate the inflammatory process by attracting
more leukocytes and increasing blood flow and vascular permeability (Goldsby, Kindt,
& Osborne, 2000; Rohde & Lee, 2003).  Enhancement of leukocyte migration may be
detrimental to recovery of function given that neutrophils and macrophages are thought
to contribute to the secondary damage that occurs following spinal cord injury.
Increases in CAM expression and subsequent leukocyte migration may be one
mechanism through which stress exacerbates a number of inflammatory diseases in both
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humans and animal models (Griffis et al., 2006).  These diseases include arthritis
(Chover-Gonzalez et al., 2000; Seres et al., 2002), asthma (Liu et al., 2002; Matalka,
2003; Okuyama et al, 2007), psoriasis (Buske-Kirschbaum et al., 2007; Folks & Kinney,
1992; Weigl, 2000), multiple sclerosis (Sieve et al., 2004), inflammatory bowel disease
(Tadakazu et al., 2007), and artherosclerosis (Blankenberg, Barbauex, & Tiret, 2003).
Viswanathan & Dhabhar (2005) showed that acutely stressed mice had a higher number
of neutrophils, macrophages, natural killer cells, and T cells that infiltrated an area of
inflammation in comparison to nonstressed animals.  They also showed that these same
animals had higher levels of lymphotactin, which is a lymphocyte specific chemokine
and TNF-!, both of which increase leukocyte trafficking.  Similar effects have been
noted after stress in individuals with psoriasis (Buske-Kirschbaum, 2007) and
rheumatoid arthritis (Liote et al., 1996).  Others have shown that increased CAM
expression is associated with disease exacerbation in rheumatoid arthritis (Liote et al.,
1996), inflammatory bowel disease (Nielson, Brynskov, & Vainer, 1996), as well as,
coronary artery disease (Blankenberg et al., 2003; Huo & Ley, 2001; Lutters et al., 2004;
Rohde & Lee, 2003).  Collectively, these findings suggest that increased CAM
expression and enhanced leukocyte migration may contribute to inflammatory diseases.
The results from Experiment 2 support both of the proposed mechanisms
discussed above.  For example, uncontrollable shock caused an increase in
corticosterone within 24 hours that persisted throughout all the timepoints tested and this
increase was accompanied by a decrease in locomotor recovery.  This finding supports
the idea that uncontrollable shock activates the HPA axis to induce the release of
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corticosterone and this increase may be detrimental to recovery.  Further studies will be
needed to determine whether the increase in corticosterone observed after uncontrollable
shock facilitates glutamatergic neurotransmission, leading to excitoxicity within the
spinal cord.  Work in the hippocampus would serve as a good model for these studies.
Several techniques have been used in that work to address the issue directly.  These
include the use of microdialysis to measure the amount of extracellular excitatory amino
acids after exposure to stress (Lowy et al., 1993), in vitro analysis of cytotoxicity in
response to glucocorticoid exposure (Mulholland et al., 2006), and measuring reuptake
of excitatory amino acids by astrocytes following exposure to glucocorticoids in vitro
(Chou, 1998).  The issue could also be addressed indirectly by determining the impact of
blocking corticosterone and/or NMDA receptors on cell death and recovery of function
in subjects given uncontrollable shock.  Our laboratory has already begun to examine the
effects of a NMDA receptor antagonist.
Experiment 2 also showed an up-regulation of IL-1" and IL-6 at the injury site
following uncontrollable shock.  Given that microglia and macrophages are the major
source of these cytokines (Hartlage-Rubsamen, Lemke, & Schliebs, 1999; Garabedian,
Lemaigre-Dubreuil, & Mariani, 2000), this suggests an increase in activated
macrophages in the spinal cord.  While this finding implies that there is an increase in
immune cell migration to the site of injury, it does not conclusively address how
uncontrollable shock produces this effect and whether it contributes to impaired recovery
of function.  Again, further studies will be needed.  These studies will need to examine
whether the uncontrollable shock regimen used in the current experiments increases pro-
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inflammatory cytokines, particularly IL-1", in the brain like other stressors (Deak et al.,
2005; Nguyen et al., 1998; O’Connor et al., 2003).  Studies will also need to show that
uncontrollable shock increases proteins involved in leukocyte trafficking, including
CAMs, and will need to definitively show an up-regulation of immune cells at the injury
site.
Summary and Conclusion
In summary, contusion injury per se had no impact on spleen weight,
corticosterone, norepinephrine, or pro-inflammatory cytokines 2 days postinjury.
Contused subjects given uncontrollable shock exhibited a locomotor deficit, had smaller
spleens, higher levels of corticosterone, and increases in IL-1" and IL-6 at the injury
site.  These effects emerged within 24 hours of shock treatment and persisted for up to 7
days. Morphine treatment did not attenuate the effects of uncontrollable shock but
instead potentiated them.  Controllability also appeared to have no impact on the
consequences of uncontrollable shock.  However, due to the type and duration of the
restraint used in the master/yoke paradigm, additional studies will be needed to further
investigate this issue.  Two mechanisms were proposed to explain the impact of
uncontrollable shock on recovery of function.  One involved corticosterone-induced
excitotoxity and the other involved cytokine enhancement of leukocyte migration to the
injury site.  Additional studies will be needed to determine which pathway(s) is/are
involved in the effects of uncontrollable shock on recovery of function after spinal cord
injury.
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Our work has important implications for recovery of function after spinal cord
injury.  Using a clinically relevant model of injury, we have shown that uncontrollable
nociceptive input induces a stress response that may result in greater loss of function.  In
human spinal cord injury, this nociceptive input may take the form of broken limbs
lacerations resulting from the accident or even neuropathic pain that results from the
injury itself.  Regardless of the source, it is imperative to prevent this type of input to the
spinal cord.  According to our findings, morphine treatment may not be the best
treatment strategy.  In fact, morphine may actually contribute to the loss of function after
spinal cord injury.  Further studies will be needed to identify clinical interventions that
can prevent the nociceptive input and preserve recovery of function.
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